3/9
08:25 am
glto
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders [Yahoo! Finance]
Medium
Report
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders [Yahoo! Finance]
3/9
08:00 am
glto
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
Low
Report
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
3/4
08:16 am
glto
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/4
08:00 am
glto
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/2
08:11 am
glto
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference [Yahoo! Finance]
Medium
Report
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference [Yahoo! Finance]
3/2
08:00 am
glto
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference
Medium
Report
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference
2/17
09:00 am
glto
Galecto (NASDAQ:GLTO) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $45.00 price target on the stock.
Low
Report
Galecto (NASDAQ:GLTO) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $45.00 price target on the stock.
2/17
08:42 am
glto
Galecto (NASDAQ:GLTO) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $40.00 price target on the stock, up previously from $36.00.
Low
Report
Galecto (NASDAQ:GLTO) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $40.00 price target on the stock, up previously from $36.00.
2/15
10:36 pm
glto
Galecto (GLTO) Is Up 15.3% After $316 Million Equity Raise And New Shelf Registration - What's Changed [Yahoo! Finance]
Medium
Report
Galecto (GLTO) Is Up 15.3% After $316 Million Equity Raise And New Shelf Registration - What's Changed [Yahoo! Finance]
2/15
12:26 pm
glto
Assessing Galecto (GLTO) Valuation After Sharp Short-Term Share Price Momentum [Yahoo! Finance]
Medium
Report
Assessing Galecto (GLTO) Valuation After Sharp Short-Term Share Price Momentum [Yahoo! Finance]
2/12
04:01 pm
glto
Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million
Low
Report
Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million
2/10
11:58 pm
glto
Galecto prices $275M stock offering [Seeking Alpha]
Medium
Report
Galecto prices $275M stock offering [Seeking Alpha]
2/10
10:42 pm
glto
Galecto Announces Pricing of $275 Million Underwritten Public Offering
Medium
Report
Galecto Announces Pricing of $275 Million Underwritten Public Offering
2/10
04:04 pm
glto
Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
Medium
Report
Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
2/3
07:12 am
glto
Galecto (NASDAQ:GLTO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Medium
Report
Galecto (NASDAQ:GLTO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
1/13
05:44 am
glto
Galecto (NASDAQ:GLTO) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
Galecto (NASDAQ:GLTO) was upgraded by analysts at Zacks Research to a "hold" rating.
1/12
08:27 am
glto
Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones [Yahoo! Finance]
Low
Report
Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones [Yahoo! Finance]
1/12
08:00 am
glto
Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones
Medium
Report
Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones
1/9
06:10 am
glto
Galecto (NASDAQ:GLTO) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Galecto (NASDAQ:GLTO) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
1/7
09:00 am
glto
Galecto (NASDAQ:GLTO) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $46.00 price target on the stock.
Medium
Report
Galecto (NASDAQ:GLTO) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $46.00 price target on the stock.
1/6
09:31 am
glto
Galecto appoints former Blueprint Medicines executives as COO and CMO [Seeking Alpha]
Low
Report
Galecto appoints former Blueprint Medicines executives as COO and CMO [Seeking Alpha]
1/6
08:00 am
glto
Galecto Announces Key Additions to Leadership Team
Low
Report
Galecto Announces Key Additions to Leadership Team